BACKGROUND & AIMS: Previous studies examining the relationship between the C282Y and H63D HFE mutations and presence of nonalcoholic fatty liver disease (NAFLD) have yielded conflicting results. The goal of this study was to systematically evaluate and summarize data on the association between these two variants and the presence of NAFLD. METHODS: The authors searched EMBASE and PUBMED from August 1, 1996 to August 12, 2010. Two investigators independently conducted data abstraction. Ethnic specific weighted prevalence was calculated and pooled odds ratios were estimated using the random effects model. RESULTS: From 2542 references, the authors included 16 case-control studies and 14 case-only studies, or 2610 cases and 7298 controls. The majority of the studies came from Caucasian populations (2287 cases and 4275 controls). The weighted prevalence of HFE mutations in cases was comparable to controls. The meta-analysis was restricted to Caucasians only because of the small sample size of non Caucasian participants. The pooled odds ratio for the presence of any HFE genetic variant in cases was 1.03 (95%CI: 0.90, 1.17; I(2): 65.8%, 95%CI: 38.5, 81.0). The presence of other genotypes and secondary analyses yielded similar non significant findings. CONCLUSIONS: Our systematic review does not support an association between the HFE genetic variants and the presence of NAFLD.
BACKGROUND & AIMS: Previous studies examining the relationship between the C282Y and H63D HFE mutations and presence of nonalcoholic fatty liver disease (NAFLD) have yielded conflicting results. The goal of this study was to systematically evaluate and summarize data on the association between these two variants and the presence of NAFLD. METHODS: The authors searched EMBASE and PUBMED from August 1, 1996 to August 12, 2010. Two investigators independently conducted data abstraction. Ethnic specific weighted prevalence was calculated and pooled odds ratios were estimated using the random effects model. RESULTS: From 2542 references, the authors included 16 case-control studies and 14 case-only studies, or 2610 cases and 7298 controls. The majority of the studies came from Caucasian populations (2287 cases and 4275 controls). The weighted prevalence of HFE mutations in cases was comparable to controls. The meta-analysis was restricted to Caucasians only because of the small sample size of non Caucasian participants. The pooled odds ratio for the presence of any HFE genetic variant in cases was 1.03 (95%CI: 0.90, 1.17; I(2): 65.8%, 95%CI: 38.5, 81.0). The presence of other genotypes and secondary analyses yielded similar non significant findings. CONCLUSIONS: Our systematic review does not support an association between the HFE genetic variants and the presence of NAFLD.
Authors: Alissa Walsh; Jeannette L Dixon; Grant A Ramm; David G Hewett; Douglas J Lincoln; Gregory J Anderson; V Nathan Subramaniam; Julian Dodemaide; Juleen A Cavanaugh; Mark L Bassett; Lawrie W Powell Journal: Clin Gastroenterol Hepatol Date: 2006-09-18 Impact factor: 11.382
Authors: M M Deguti; A M Sipahi; L C C Gayotto; S A Palácios; P L Bittencourt; A C Goldberg; A A Laudanna; F J Carrilho; E L R Cançado Journal: Braz J Med Biol Res Date: 2003-06-03 Impact factor: 2.590
Authors: Shunji Tomatsu; Koji O Orii; Robert E Fleming; Christopher C Holden; Abdul Waheed; Robert S Britton; Monica A Gutierrez; Susana Velez-Castrillon; Bruce R Bacon; William S Sly Journal: Proc Natl Acad Sci U S A Date: 2003-12-12 Impact factor: 11.205
Authors: Shivakumar Chitturi; Martin Weltman; Geoffrey C Farrell; David McDonald; James Kench; Christopher Liddle; Dev Samarasinghe; Rita Lin; Shehan Abeygunasekera; Jacob George Journal: Hepatology Date: 2002-07 Impact factor: 17.425
Authors: Ruben Hernaez; Edwina Yeung; Jeanne M Clark; Kris V Kowdley; Frederick L Brancati; Wen Hong Linda Kao Journal: J Hepatol Date: 2011-02-24 Impact factor: 25.083